연구성과로 돌아가기

2020 연구성과별 연구자 정보 (953 / 2428)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation Lee, Kyoung Tae Lee, KT 9 Natl Inst Forest Sci, Forest Biomat Res Ctr, Jinju 52817, South Korea A-7768-2017 Kim, Kyoung-Sook neelakagm2012@gmail.com;hasikarunarathne@gmail.com;srpark@jejunu.ac.kr;choiyh@deu.ac.kr;epark@knu.ac.kr;cyjin@zzu.edu.cn;yuhaiyang19830116@hotmail.com;sailorjo@dirams.re.kr;leekt99@korea.kr;immunkim@jejunu.ac.kr;
GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation Kim, Gi-Young Kim, GY 10 교신저자 Jeju Natl Univ, Dept Marine Life Sci, Jeju 63243, South Korea 0000-0002-6878-0790 Kim, Gi-Young neelakagm2012@gmail.com;hasikarunarathne@gmail.com;srpark@jejunu.ac.kr;choiyh@deu.ac.kr;epark@knu.ac.kr;cyjin@zzu.edu.cn;yuhaiyang19830116@hotmail.com;sailorjo@dirams.re.kr;leekt99@korea.kr;immunkim@jejunu.ac.kr;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Kim, David Kim, D 1 Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea AAK-5424-2020 Kim, Jin-Seok powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Lee, Jae Seung Lee, JS 2 Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea KHT-9575-2024 LEE, JAE SEUNG powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Chun, Ho Soo Chun, HS 3 Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Lee, Hye Won Lee, HW 4 Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Kim, Beom Kyung Kim, BK 5 Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Park, Jun Yong Park, JY 6 Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea H-7127-2019 Park, Jun powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Kim, Do Young Kim, DY 7 Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Han, Kwang-Hyub Han, KH 8 Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Lee, Yu Rim Lee, YR 9 Kyungpook Natl Univ, Dept Internal Med, Daegu, South Korea powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Tak, Won Young Tak, WY 10 Kyungpook Natl Univ, Dept Internal Med, Daegu, South Korea powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Kweon, Young Oh Kweon, YO 11 Kyungpook Natl Univ, Dept Internal Med, Daegu, South Korea powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Ahn, Sang Hoon Ahn, SH 12 Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea AAV-2600-2020 SANG-HOON, AHN powerof1004@gmail.com;
Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea Kim, Seung Up Kim, SU 13 Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea D-5804-2019 Kim, Hyongbum powerof1004@gmail.com;
페이지 이동: